Miaoxiang Notoginseng Brand originated in 1946. Mr. Yu Heqian planted Notoginseng in Xigu Village, Wenshan, Yunnan Province, which is the origin of the notoginseng. The company was founded in 2001. Now it has formed a high-quality notoginseng whole industry chain integrating scientific research, planting, processing, raw material and terminal product development, domestic and foreign sales and service providing, realizing the whole process of controllable traceability from seed source to product.

With science and technology as the primary productive force, Miaoxiang Notoginseng Science and Technology Demonstration Park of more than 500 mu has been built, and over 30 scientific research institutions at home and abroad have cooperated to carry out research in the fields of Notoginseng resource production, processing, standards and so on, with more than 100 patents have been obtained by now. Among them, the new varieties "Miaoxiang No. 1" and "Miaoxiang No. 2" selected by Miaoxiang have won the new plant variety right of the state for the first time;

The promotion rate of the new-type notoginseng special sunshade construction, solar greenhouse notoginseng drying and other patented technologies developed by Miao Xiang in the industry is more than 80%, ultimately providing safe, effective and stable notoginseng products to the market, effectively promoting the sustainable and healthy development of the industry. In 2017, Miao Xiang was awarded The Second Prize of National Science and Technology Progress by the State Council; In 2018, Miao Xiang was recognized as "National Intellectual Property Advantage Enterprise" by the Ministry of Science and Technology of China.

Miaoxiang notoginseng has been exported for 19 years with organic certification of Japan, the European Union, the United States and China since 2001. It has two brands, namely "Miaoxiang Notoginseng" and "Heqian Notoginseng", which respectively provide organic notoginseng, pollution-free notoginseng and Chinese pharmacopoeia standard notoginseng products for pharmaceutical enterprises, chain drugstores, hospitals, traditional Chinese medicine stores and consumers.